Clinical trials recruiting for Diffuse Cutaneous Systemic Sclerosis
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CTX112 | 1 |
| Cyclophosphamide | 1 |
| Fludarabine | 1 |
| QEL-005 | 1 |
| zamtocabtagene autoleucel | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Illinois | 1 |
| Iowa | 1 |
| Louisiana | 1 |
| Massachusetts | 1 |
| Missouri | 1 |
| North Carolina | 1 |
| Oregon | 1 |
| Wisconsin | 1 |
Top cities
Self-screener
Recruiting trials
- A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- Controlling Hyperactive Immunity With Long-lived Lymphocytes
- US Zamto-cel Autoimmune Diseases
Related conditions
Trials recruiting for Diffuse Cutaneous Systemic Sclerosis often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Diffuse Cutaneous Systemic Sclerosis trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.